Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-03

FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)

View source ↗

Summary

FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole (Ketoconazole)

Snippet

SUPPL AP for KETOCONAZOLE (KETOCONAZOLE)